Jeffrey S Elmendorf – Clinical relevance of cholesterol in metabolic health and disease
Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies.
1. Why is cholesterol of interest for metabolic health and disease? (0:07)
2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical findings? (0:50)
3. Are there data that explain the incidence of increased type 2 diabetes risk with statin therapy? (1:27)
4. How does pitavastatin differ in having a favorable impact on metabolic health? (3:18)
View the full article here.
Speaker disclosures: Jeffrey S Elmendorf has nothing to declare in relation to this video interview.
Support: The publication of this video was supported by Kowa Pharmaceuticals America who was given the opportunity to review the video for scientific accuracy before publication. Any resulting changes were made at the author’s/authors’ discretion.
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022 in diabetes
2022 saw the FDA approval of teplizumab to delay the onset of type 1 diabetes. In addition, there has also been evidence to suggest the effectivness of SGLT2 inhibitors in type 1 diabetes. We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!